230
Views
4
CrossRef citations to date
0
Altmetric
Original Article

Effects of Interferons and Tumour Necrosis Factor-α on Human Lung Cancer Cell Lines and the Development of an Interferon-Resistant Lung Cancer Cell Line

, , , , &
Pages 473-478 | Received 09 Dec 1994, Accepted 10 Jul 1995, Published online: 08 Jul 2009
 

Abstract

Thirteen human lung cancer cell lines, 7 representing small cell lung cancer (SCLC) and 6 different types of non-SCLC, were tested for sensitivity to tumour necrosis factor alpha (TNF-α) and interferon alpha and gamma (IFN-α and γ) using an automated fluorometric microculture cytotoxicity assay (FMCA). One SCLC line (H-82) was found to be sensitive to IFN-α in short-term (72 h) culture, whereas after prolonged (5 days) culture two additional SCLC cell lines responded to IFN-γ. TNF-α inhibited the growth of one large cell carcinoma cell line (H-157), whereas all SCLC lines were found to be insensitive. The combination of IFN-γ and TNF-α produced no further response compared with the single agents used alone. By continuous cultivation of the IFN-α-sensitive cell line H-82 in the presence of increasing concentrations of IFN-α, an IFN-α-resistant subline (H-82R) was established. This line displayed a high degree of resistance (>100 fold) to IFN-α and cross-resistance to IFN-γ. There was no alteration in the number of IFN binding sites, in the growth rate, the expression of selected surface markers for SCLC or the expression of multidrug resistance markers in the H-82R subline compared with the parental H-82 cell line. The results demonstrate a heterogeneous response of SCLC cell lines to IFN-α and γ and TNF-α with only a minority of the cell lines responding to these agents by growth inhibition. The IFN-α and γ H-82R subline may serve as a valuable tool in future studies on the mechanisms of IFN antitumour activity.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.